FIELD: medicine.
SUBSTANCE: place the patient or a part of his body tested on oncological disease in a shielded space with residual magnetic induction 42 mkTl>Brest>250 nTl and the factor of shielding higher than 1. Duration of an exposition makes t>40 minutes, quantity of sessions N≥1.
EFFECT: offered invention allows carrying out correction of human diseases.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CORRECTING GEOPHYSICAL ENVIRONMENT-FACTOR-DEPENDENT FUNCTIONAL DISORDERS AND DISEASES | 1999 |
|
RU2179868C2 |
| APPARATUS FOR INVESTIGATING EFFECT OF ELECTROMAGNETIC FIELDS ON BIOLOGICAL OBJECTS | 2008 |
|
RU2454675C2 |
| METHOD FOR PREVENTING AND TREATING IMMUNODEFICIENCY STATES OF MAMMALIAN BY APPLYING WEAK COMBINED ELECTROMAGNETIC FIELDS | 2002 |
|
RU2207889C1 |
| METHOD OF PREVENTING STRESSOGENIC DISORDERS IN PEOPLE | 2011 |
|
RU2469755C1 |
| MEANS THAT HAS HELIO- AND GEOMAGNETIC-PROTECTOR PROPERTIES | 2007 |
|
RU2342149C1 |
| METHOD OF PROVIDING GIVEN LEVEL OF MAGNITUDE OF HYPOGEOMAGNETIC FIELD INDUCTION VECTOR IN CYLINDRICAL SCREENING CHAMBER AND APPARATUS THEREFOR | 2013 |
|
RU2545466C2 |
| METHOD FOR APPLYING BIOENERGETIC SYSTEM THERAPY | 2002 |
|
RU2294777C2 |
| METHOD OF REPRODUCING MAGNETIC INDUCTION IN HYPOGEOMAGNETIC RANGE | 2017 |
|
RU2650769C1 |
| METHOD FOR RELIEF OF PERIPHERAL NEUROGENIC CHRONIC PAIN SYNDROME | 2017 |
|
RU2645948C1 |
| METHOD OF DETERMINING THE SENSITIVITY OF BAROREFLEX REGULATION OF THE HEART RATE TO VARIATIONS IN THE LOCAL GEOMAGNETIC FIELD IN HUMANS | 2021 |
|
RU2798780C2 |
